Radioimmunoscintigraphy with Tc-99m-labelled SM3 in differentiating malignant from benign adnexal masses

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 110, Issue 5, 2003, Pages 508-514

  Ali, N ^a   Jan, H ^a   Van Trappen, P ^a   Nasreen, F ^a   Canizales, A ^a   Carroll, M J ^a   Granowska, M ^a   Jacobs, I ^a   Britton, K E ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOPHARMACEUTICAL AGENT; STRIPPED MUCIN 3 ANTIBODY TC 99M; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; FEMALE; FEMALE GENITAL SYSTEM; HUMAN; IMMUNOSCINTIGRAPHY; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; OVARY CARCINOMA; OVARY TUMOR; PELVIS; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0037722860     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-0528.2003.02186.x     Document Type: Article

References (16)

1. Jacobs I., Oram D., Fairbanks Jet al. A risk of malignancy index incorporating CA125, ultrasound and menopausal status after the accurate pre-operative diagnosis of ovarian cancer. Br J Obstet Gynaecol. 97:1990;922-929.
2. Davies A.P., Jacobs I., Woolas Ret al. Adnexal mass: benign or malignant? Evaluation of a risk of malignant index. Br J Obstet Gynaecol. 100:1993;927-931.
3. Tingulstad S., Hagen B., Skjeldestad F.E., Halvorsen T., Nustad K., Onsrud M. The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals. Obstet Gynecol. 93:1999;448-452.
4. Tingulstad S., Hagen B., Skjeldestad FEet al. Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre-operative diagnosis of pelvic masses. Br J Obstet Gynaecol. 103:1996;826-831.
5. Burchell J., Gendler S., Taylor-Papadimitriou Jet al. Development and characterisation of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res. 47:1987;5476-5482.
6. Granowska M., Britton K.E., Mather SJet al. Radioimmunoscintigraphy with technetium-99m-labelled monoclonal antibody, SM3, in gynaecological cancer. Eur J Nucl Med. 20:1993;483-489.
7. Britton K.E., Granowska M. Radioimmunoscintigraphy in tumour identification. Cancer Surv. 6:1987;247-267.
8. Mather S.J., Ellison D. Reduction mediated technetium labelling of monoclonal antibodies. J Nucl Med. 31:1990;692-697.
9. Granowska M., Nimmon C.C., Britton KEet al. Kinetic analysis and probability mapping applied to detection of ovarian cancer by immunoscintigraphy. J Nucl Med. 29:1988;599-607.
10. 99mTc-labelled SM3 in the preoperative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detection. Br J Cancer. 77:1998;131-138.
11. Taylor-Papadimitriou J., Paterson J.A., Arkle Jet al. Monoclonal antibodies to epithelium specific component of the human milk fat globule membrane production and reaction with cells in culture. Int J Cancer. 28:1981;17-21.
12. Epenetos A.A., Britton K.E., Mather SJet al. Targeting of iodine-123 labelled tumour-associated monoclonal antibodies to ovarian, breast and gastrointestinal tumours. Lancet. ii:1982;999-1005.
13. Bast R.C., Klug T.L., St John Eet al. Radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 309:1983;169-171.
14. Schlom J. Basic principles and applications of monoclonal antibodies in the management of carcinomas. The Richard and Hilda Rosenthal Foundation Award Lecture. Cancer Res. 46:1986;3225-3238.
15. Tibben J.B., Massuger LFAG, Claessens RMNJet al. Clinical Experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence. Nucl Med Commun. 20:1999;689-696.
16. Alexander C., Villenal-Heinsen C.E., Schaefer Aet al. Monoclonal antibody MAb-170 for immunoscintigraphic detection of ovarian tumors. Am J Obstet Gynecol. 181:1999;513-517.